Clinical Trial Results:
ENSAYO CLÍNICO MULTICÉNTRICO FASE I/II ALEATORIZADO Y CONTROLADO CON PLACEBO, PARA EVALUACIÓN DE SEGURIDAD Y FACTIBILIDAD DE LA TERAPIA CON DOS DOSIS DISTINTAS DE CÉLULAS TRONCALES MESENQUIMALES AUTÓLOGAS DE TEJIDO ADIPOSO (CETMAD) EN PACIENTES CON ESCLEROSIS MÚLTIPLE SECUNDARIAMENTE PROGRESIVA, QUE NO RESPONDEN ADECUADAMENTE A LOS TRATAMIENTOS REGISTRADOS.
Summary
|
|
EudraCT number |
2008-004015-35 |
Trial protocol |
ES |
Global completion date |
28 Jun 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Oct 2020
|
First version publication date |
04 Oct 2020
|
Other versions |
|
Summary report(s) |
2008-004015-35 synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.